Latest Manufacturing News

News Corporation reported a robust half-year performance with revenues up 4% to $4.33 billion and net income soaring 80% to $334 million, while advancing its strategic pivot through the planned sale of Foxtel.

Northern Minerals has completed the second tranche of its placement, raising $41.5 million to advance its Browns Range Heavy Rare Earth Project, focusing on the high-grade Wolverine deposit.

Micro-X Ltd has announced a $6 million capital raising alongside a $2.4 million strategic investment from Billion Prima, underpinning its pivot towards medical imaging and cashflow stability.

Eureka Group Holdings has acquired a mixed-use residential park in Gladstone, marking its strategic entry into the all-age rental market with promising yield and expansion potential.

Resouro Strategic Metals reports outstanding assay results from its Tiros Central Project in Brazil, revealing high-grade titanium dioxide and rare earth elements that underscore the project's global significance.

AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.

The Calmer Co. International Limited has secured a FJD2.64 million loan from Fiji Development Bank to acquire its Navua manufacturing site, marking a strategic step to enhance production and market presence in the global kava industry.

Vitrafy Life Sciences reports strong progress in cryopreservation technology development and US market expansion following a successful $35 million IPO. The company highlights improved biological sample preservation outcomes and strategic commercial milestones.

Little Green Pharma has finalized the acquisition of Health House, a key medicinal cannabis distributor, for a fraction of its previous valuation, marking a strategic move to deepen vertical integration.

VRX Silica Limited's Arrowsmith North silica sand project faces a formal appeal from the Conservation Council of WA, challenging the recent environmental approval recommendation. The company is preparing its response while continuing to advance parallel permitting processes.

A new peer-reviewed study highlights Cynata Therapeutics’ Cymerus™ iPSC-derived MSCs as superior to traditional donor tissue-derived MSCs in potency, consistency, and regenerative potential.

Audeara Limited has landed a significant US$917,000 follow-up purchase order from a global music instrument manufacturer, reinforcing the commercial viability of its hearing technology and expanding its licensing footprint.